Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence

SIMPLE SUMMARY: Locoregional therapies such as surgical resection, liver transplantation, and ablative techniques are preferred for early-stage HCC management. However, 70–80% of patients report HCC recurrence within 5 years of curative treatment. During the initiation and establishment of carcinoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Devan, Aswathy R., Nair, Bhagyalakshmi, Aryan, Manu Kanjoormana, Liju, Vijayastelar B., Koshy, Joel Joy, Mathew, Bijo, Valsan, Arun, Kim, Hoon, Nath, Lekshmi R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216348/
https://www.ncbi.nlm.nih.gov/pubmed/37345066
http://dx.doi.org/10.3390/cancers15102729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216348/
https://www.ncbi.nlm.nih.gov/pubmed/37345066
http://dx.doi.org/10.3390/cancers15102729

Ejemplares similares